CEACAM5 and neoplasm: In contrast, an MLM-negative case showed protective effects from an N0 stage, low CEA (1 ng/mL), well-differentiated tumor (G1–2), and moderate SII (521), despite positive contributions from vascular invasion (+0.0922) and four other features (+0.164), resulting in a final prediction below baseline (Figure 6D).